25 Years of Research and the GT103 Antibody: A Deep Dive
New Immunotherapy Combination Shows Promise in Advanced Cancers A novel immunotherapy approach combining an experimental antibody with pembrolizumab, a widely used immunotherapy drug, is showing early signs of promise in treating advanced cancers, according to research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.The research,led by Dr. Emily Patz and Dr. … Read more